KR910004620A - 위궤양 치료제 - Google Patents
위궤양 치료제 Download PDFInfo
- Publication number
- KR910004620A KR910004620A KR1019900012571A KR900012571A KR910004620A KR 910004620 A KR910004620 A KR 910004620A KR 1019900012571 A KR1019900012571 A KR 1019900012571A KR 900012571 A KR900012571 A KR 900012571A KR 910004620 A KR910004620 A KR 910004620A
- Authority
- KR
- South Korea
- Prior art keywords
- ethyl
- compound
- alkyl
- methyl
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 하나 이상의 일반식(I)의 화합물의 유효량을 포함하는 위궤양 치료제.상기식에서, R1및 R3중의 하나는[여기서, m은 1 내지 5이고, R4는 (C1-C4)알킬 그룹이다)] 이고, 다른 하나는 수소 (C3-C6)알케닐, 또는 2개 이하의 하이드록실 또는 (C1-C4)알콕시 그룹에 의해 치환될 수 있는 (C1-C8)알킬이며, R2는 (C1-C4)알킬이다.
- 제1항에 있어서, R1및 R3중의 하나가(여기서, m은 3,4또는 5이고, R4는 메틸 또는 에틸이다)이고, 다른 하나는 수소, (C3-C4)알케닐, 또는 2개 이하의 하이드록실 그룹 또는 (C1-C2) 알콕시 그룹에 의해 임의로 치환된 (C1-C4)알킬이며, R2는 메틸 또는 에틸임을 특징으로 하는 치료제.
- 제1항 또는 2항에 있어서, R1및 R3중의 하나가(여기서, m은 4 또는 5이다)이고, 다른 하나는 (C1-C4)알킬 또는(C1-C2)알콕시 그룹에 의해 임의로 치환된 (C1-C4)알킬이며, R2가 에틸임을 특징으로 하는 치료제.
- 제1항 내지 3항중 어느 한 항에 있어서, R1이(여기서, m은 4 또는 5이다)이고, R3이 (C1-C4)알킬 또는 (C1-C2)알콕시 ;그룹에 의해 임의로 치환된 (C1-C4)알킬이며, R2가 에틸임을 특징으로 하는 치료제.
- (a) R2가 에틸이고, R1이 6-하이드록시-6-메틸헵틸이며 R3가 에틸, 프로필 또는 어소프로필이거나, 또는 (b) R2가 에틸이고, R1이 5-하이드록시-5-메틸헥실이며 R3가 에틸 또는 부틸인 제1항에 따른 일반식(I)의 화합물.
- R1및 R3중의 하나가[여기서, m은 1 내지 5이고 R4는 (C1-C2)알킬 그룹이다]이고, 다른 하나는 (C3-C6) 알케닐이며 R2가 (C1-C4) 알킬린, 7-(3-부테닐)-1-5-하이드록시-5-메틸헥실)-3-메틸 크산틴을 제외한 제1항에 따른 일반식(I)의 화합물.
- 제6항에 있어서, R1및 R3중의 하나가[여기서, m은 3, 4 또는 5이고 R4는 메틸 또는 에틸이다)이고, 다른 하나는 (C3-C4) 알킬렌이며 R2가 메틸 또는 에틸인, 7-(3-부테닐)-1-(5-하이드록시-5-메틸헥실)-3-메틸크산틴을 제외한 제1항에 따른 일반식(I)의 화합물.
- 제6항 또는 7항에 있어서, R1및 R3중의(여기서, m은 4이고 R4는 메틸이다)이고, 다른 하나는 알릴 또는 부테닐이며 R2가 메틸 또는 에틸인, 7-(3-부테닐)-1-(5-하이드록시-5-메틸헥실)-3-메틸크산틴을 제외한 일반식(I)의 화합물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21018789 | 1989-08-16 | ||
JP210187/89 | 1989-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR910004620A true KR910004620A (ko) | 1991-03-29 |
Family
ID=16585226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900012571A KR910004620A (ko) | 1989-08-16 | 1990-08-16 | 위궤양 치료제 |
Country Status (18)
Country | Link |
---|---|
US (1) | US5109003A (ko) |
EP (1) | EP0413278B1 (ko) |
JP (1) | JP2977242B2 (ko) |
KR (1) | KR910004620A (ko) |
AT (1) | ATE144900T1 (ko) |
AU (1) | AU624987B2 (ko) |
CA (1) | CA2023310A1 (ko) |
DD (1) | DD298051A5 (ko) |
DE (1) | DE69029069T2 (ko) |
DK (1) | DK0413278T3 (ko) |
ES (1) | ES2094132T3 (ko) |
GR (1) | GR3021569T3 (ko) |
HU (1) | HU207518B (ko) |
IE (1) | IE902954A1 (ko) |
IL (1) | IL95377A (ko) |
NZ (1) | NZ234896A (ko) |
PT (1) | PT95007A (ko) |
ZA (1) | ZA906446B (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
US5354756A (en) * | 1993-01-12 | 1994-10-11 | Cell Therapeutics, Inc. | Olefin-substituted long chain xanthine compounds |
DE4411660A1 (de) * | 1994-04-05 | 1995-10-12 | Hoechst Ag | Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung |
US7122207B2 (en) * | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
JPS63225317A (ja) * | 1986-10-06 | 1988-09-20 | Hoechst Japan Kk | 抗消化性潰瘍剤 |
IL106854A (en) * | 1986-12-31 | 1996-05-14 | Hoechst Roussel Pharma | Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard |
JP2661666B2 (ja) * | 1988-02-19 | 1997-10-08 | ヘキスト薬品工業株式会社 | 抗消化性潰瘍剤 |
-
1990
- 1990-07-30 DD DD90343153A patent/DD298051A5/de not_active IP Right Cessation
- 1990-08-10 JP JP2210334A patent/JP2977242B2/ja not_active Expired - Lifetime
- 1990-08-11 DK DK90115456.7T patent/DK0413278T3/da active
- 1990-08-11 AT AT90115456T patent/ATE144900T1/de not_active IP Right Cessation
- 1990-08-11 DE DE69029069T patent/DE69029069T2/de not_active Expired - Fee Related
- 1990-08-11 EP EP90115456A patent/EP0413278B1/en not_active Expired - Lifetime
- 1990-08-11 ES ES90115456T patent/ES2094132T3/es not_active Expired - Lifetime
- 1990-08-14 US US07/566,756 patent/US5109003A/en not_active Expired - Fee Related
- 1990-08-14 IL IL9537790A patent/IL95377A/en not_active IP Right Cessation
- 1990-08-14 HU HU905000A patent/HU207518B/hu not_active IP Right Cessation
- 1990-08-14 NZ NZ234896A patent/NZ234896A/en unknown
- 1990-08-15 CA CA002023310A patent/CA2023310A1/en not_active Abandoned
- 1990-08-15 AU AU61018/90A patent/AU624987B2/en not_active Ceased
- 1990-08-15 ZA ZA906446A patent/ZA906446B/xx unknown
- 1990-08-15 IE IE295490A patent/IE902954A1/en unknown
- 1990-08-16 KR KR1019900012571A patent/KR910004620A/ko active IP Right Grant
- 1990-08-16 PT PT95007A patent/PT95007A/pt not_active Application Discontinuation
-
1996
- 1996-11-07 GR GR960402903T patent/GR3021569T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HU207518B (en) | 1993-04-28 |
IE902954A1 (en) | 1991-02-27 |
EP0413278A2 (en) | 1991-02-20 |
ES2094132T3 (es) | 1997-01-16 |
IL95377A (en) | 1994-08-26 |
DK0413278T3 (da) | 1997-04-07 |
JPH03163019A (ja) | 1991-07-15 |
US5109003A (en) | 1992-04-28 |
DD298051A5 (de) | 1992-02-06 |
ATE144900T1 (de) | 1996-11-15 |
AU6101890A (en) | 1991-02-21 |
ZA906446B (en) | 1991-05-29 |
NZ234896A (en) | 1993-10-26 |
JP2977242B2 (ja) | 1999-11-15 |
EP0413278A3 (en) | 1992-05-06 |
GR3021569T3 (en) | 1997-02-28 |
AU624987B2 (en) | 1992-06-25 |
EP0413278B1 (en) | 1996-11-06 |
HU905000D0 (en) | 1991-01-28 |
IL95377A0 (en) | 1991-06-30 |
PT95007A (pt) | 1991-04-18 |
DE69029069T2 (de) | 1997-04-10 |
CA2023310A1 (en) | 1991-02-17 |
HUT54688A (en) | 1991-03-28 |
DE69029069D1 (de) | 1996-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3880047D1 (de) | Zusammensetzung eines zusatzes. | |
KR890004709A (ko) | 항원충제로서의 아지트로마이신 및 이의 유도체 | |
IT7923417A0 (it) | Composizione comprendente un polimero o un'emulsione acquosa di polimero utile come agente addensante in composizioni acquose | |
IT7827882A0 (it) | Struttura di piattaforma d'alto mare. | |
DE3779461D1 (de) | Durch alkylgruppen substituiertes phenylcarbamat von polysaccharid. | |
KR840000236A (ko) | 포유류의 국부용 제형의 수분 손실량을 극소화시키는 방법 | |
KR920000746A (ko) | 아미노벤조디아제핀 | |
KR890008086A (ko) | 사이클로헥산 유도체 | |
NO882639D0 (no) | Komposisjoner inneholdende poly(vinylaminer) med hoey molekylvekt for assistert oljeutvinning. | |
KR850002377A (ko) | 살충제 조성물 | |
OA07525A (fr) | Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés. | |
KR970061246A (ko) | 테스토스테론을 증가시키기 위한 약학 조성물 | |
KR910004620A (ko) | 위궤양 치료제 | |
KR890006744A (ko) | 에폭시 수지 조성물 | |
KR910004557A (ko) | 2,4,6-치환 페놀 유도체 | |
IT8722869A0 (it) | Soluzioni iniettabili pronte all'uso contenenti un glicoside antraciclinico antitumorale. | |
KR880007494A (ko) | 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도 | |
ATE106438T1 (de) | Benzotriazolderivate enthaltende schmiermittelzusammensetzungen. | |
KR880002542A (ko) | 항종양제 | |
KR880004810A (ko) | 소화성 궤양 치료제 | |
KR920702685A (ko) | 4,6-o- 히드록시포스포릴글루코사민 유도체 | |
KR920008012A (ko) | 트리아졸 유도체 | |
KR920702676A (ko) | 신규 입체이성질체 | |
JPS5536258A (en) | Preparation of aqueous dispersion of silicone | |
KR840004431A (ko) | 히단토인 치료제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |